Andere talen TalkMed Group Limited

Aandelen

5G3

SG2G61000003

Beurs gesloten - Singapore S.E. Andere beurzen 10:48:02 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,415 ^SGD	+3,75%		-1,19%	+9,21%

20/02	TalkMed Group Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	TalkMed Group Limited kondigt bestuurswijzigingen aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

TalkMed Group Limited Approves Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2023	18/04
TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal	17/04
TalkMed Group Awards 1.1 Million New Shares	14/03
TalkMed's H2 Attributable Profit Falls on Wider Impairment Loss	21/02
Talkmed Group Limited Proposes Tax Exempt (One-Tier) Final Dividend for the Financial Year Ended 31 December 2023, Payable on 10 May 2024	20/02
TalkMed Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
TalkMed Group Grants Nearly 8 Million Share Awards Under Performance Share Plan	20/12
TalkMed Group Limited Announces Management Changes	10/11
TalkMed Group Limited Announces Re-Designation of Leong Ching Ching from Non-Executive Director to Independent Non-Executive Director and Appoints as Chairman of the Remuneration Committee, Effective January 1, 2024	10/11
TalkMed Group Limited Announces Re-Designation of S. Chandra Das from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024	10/11
TalkMed Group Limited Announces Re-Designation of Sitoh Yih Pin from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024	10/11
Talkmed Group Limited Appoints Khoo Kei Siong as Alternate Director to Ang Peng Tiam, Effective January 1, 2024	10/11
TalkMed Group Limited Appoints Dr Tan Khai Tong as Independent Non-Executive Director, Member of the Remuneration Committee, Effective January 1, 2024	10/11
TalkMed Group Limited Appoints Peter Sim Swee Yam as Independent Non-Executive Director, Chairman of the Nominating Committee, Member of the Audit and Risk Committee, Effective January 1, 2024	10/11
TalkMed Group Limited Appoints Lam Kok Shang as Independent Non-Executive Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee, Effective January 1, 2024	10/11
TalkMed Group Issues New Shares Upon Vesting of Share Awards	19-10-23
TalkMed Group Issues New Shares Upon Vesting of Share Awards	17-10-23
Singapore Stocks Track Global Gains to Close Higher; Delfi Shares Jump 3% on Higher H1 Profit, Revenue	08-08-23
TalkMed Group's Attributable Profit Zooms 18% in H1	08-08-23
TalkMed Group Limited Declares Tax Exempt (One-Tier) Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 22 August 2023	07-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen TalkMed Group Limited

Aandelen

5G3

SG2G61000003

Andere talen

Filters